Larvol Delta - Tejas-Safety-Tolerability-and-PK-of-Subcutaneous-D45172-in-Subjects-With-Wet-AMD-or-DME

migaldendranib subcutaneous (D-4517.2 SC) - Ashvattha Therap

Eylea (aflibercept intravitreal) - Regeneron

http://clinicaltrials.gov/ct2/show/NCT05387837

May 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next